SafeMinds 2008 Press Releases
Researchers & Department of Defense Question Multiple Vaccine Administration
SafeMinds asks, “Is Mercury a Common Factor?”
December 2008 SafeMinds Press Release
Two new reports announced last week call into question the safety of the Centers for Disease Control (CDC) decade’s old policy of routinely administering multiple vaccines concurrently. Mitochondrial Disease in Autism Spectrum Disorder Patients, published last week in PLOS One by investigators from the Cleveland Clinic, Johns Hopkins Kennedy Krieger Institute and Massachusetts General Hospital concluded that disturbance in mitochondria (energy production cells) is an underlying mechanism in a subset of individuals with autism. Read more.
View mercury/mitochondrial research.
Infant Vaccines Product Autism Symptoms in New Primate Study by University of Pittsburgh Scientists
Routine safety study that government scientists refused to do illustrates vaccines program and mercury health risks.
May 19, 2008 SafeMinds Press Releas
ATLANTA, GA –Findings released today showed that infant monkeys given vaccines officially recommended by the CDC and the American Academy of Pediatrics (AAP) exhibited autism-like symptoms. Lead investigator Laura Hewitson of the University of Pittsburgh and colleagues presented study results at the International Meeting for Autism Research (IMFAR) in London. Safety studies of medicines are typically conducted in monkeys prior to use in humans, yet such basic research on the current childhood vaccination regimen has never before been done. Read more.
Autism Incidence Increased by Mercury Emissions
May 1, 2008 SafeMinds Press Release
A paper published in the medical journal Health & Place found that children living next to a mercury polluter have a higher risk of developing autism. The research, from University of Texas Health Science Center (San Antonio), by researchers Raymond Palmer, PhD and colleagues, determined that a community’s distance to a coal-fired powered plant, or other industrial mercury source, significantly predicts future autism rates in the community’s schoolchildren. Read more.
Wakefield and Colleagues Should Be Knighted, Not Persecuted
U.K. Medical Inquiry Threatens Scientific Inquiry & Progress in Autism
March 27, 2008 SafeMinds and National Autism Association Joint Press Release
The National Autism Association (NAA), SafeMinds, Unlocking Autism, Generation Rescue, Autism One and Talk About Curing Autism (TACA) wish to express support for Dr. Andrew Wakefield and his colleagues who are unjustly facing a fitness to practice hearing by the General Medical Council (GMC) of the United Kingdom. Dr. Wakefield, a pioneer in autism research and treatment, begins his historic testimony today. The undersigned organizations, along with other U.S. families affected by autism, join in spirit with the U.K. families who are demonstrating today at the GMC offices in London. Read more.
ABC Drama, Eli Stone, Tackles Autism-Thimerosal Controversy
SafeMinds asks network for balanced viewer information despite AAP pressure
January 29, 2008 SafeMinds Press Release
SafeMinds has formally asked ABC to resist the latest attempt by the American Academy of Pediatrics (AAP) to stifle public discussion on the link between thimerosal and autism. According to an article published in the New York Times last week, the premiere episode of Eli Stone, an ABC drama, depicts the main character, Eli Stone, successfully bringing a mother’s lawsuit to court against a pharmaceutical company claiming that a vaccine additive, “mercuritol”, in their influenza vaccine caused her son’s autism. ‘Mecuritol’ resembles the real-life mercury-containing compound thimerosal, used in infant vaccines as a preservative. Read more.
PAGE OPTIONS